Shekel

Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2023

Retrieved on: 
Sunday, March 31, 2024
Shekel, Season, Tax, Agreement, Dorad Power Station, SWAP, Sale, P-50, Depreciation, Disclosure, Bank statement, RDL, Electricity, Klahim, Legislation, AMPA, Iron, Public expenditure, Good, Israeli new shekel, PPA, Zorlu, Komemiyut, Bank Mizrahi-Tefahot, Acquisition, PV, EBIDTA, Loss, D&O, Greenhouse, Government, Total, Renewable energy

•  Operating expenses were approximately €22.9 million for the year ended December 31, 2023, compared to approximately €23.7 million for the year ended December 31, 2022.

Key Points: 
  • •  Operating expenses were approximately €22.9 million for the year ended December 31, 2023, compared to approximately €23.7 million for the year ended December 31, 2022.
  • •  Project development costs were approximately €4.5 million for the year ended December 31, 2023, compared to approximately €3.8 million for the year ended December 31, 2022.
  • During 2023, the Ellomay Solar project (28 MW) produced revenues from the sale of electricity and green certificates of approximately €4 million.
  • The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results.

Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹

Retrieved on: 
Thursday, February 29, 2024
Shekel, Vii, Peace, Pressure, Research, Investment, Flower, Average cost, Growth, CBN, Sale, Cannabinoid, Wind, Capital expenditure, Genetics, CBG, GMO, Edible, Patient, CBD, Tax, CBC, Capital, Cannabinol, Lord, Bank statement, Depreciation, Drug

In Israel, Cronos launched three new flower offerings under the Peace Naturals® brand in the fourth quarter, Rockstar, Dancehall, and Sonic Fuel.

Key Points: 
  • In Israel, Cronos launched three new flower offerings under the Peace Naturals® brand in the fourth quarter, Rockstar, Dancehall, and Sonic Fuel.
  • Cronos GrowCo reported to the Company preliminary unaudited net revenue to licensed producers excluding sales to the Company in the fourth quarter and full-year 2023 of approximately $6.6 million and $19.6 million, respectively.
  • In addition to principal repayment, Cronos also received approximately $10.3 million in interest payments from GrowCo in 2023, resulting in a total of approximately $15.9 million in cash payments to Cronos in 2023.
  • ET to discuss 2023 Fourth Quarter and Full-Year business results.

Enlight Renewable Energy Reports Fourth Quarter 2023 Financial Results

Retrieved on: 
Monday, February 26, 2024
Shekel, International, Hamas, Environment, health and safety, PIN, Forecasting, Weather, Annual report, Investment, Safety, Growth, Table, Terrorism, Renewable energy, Enlight, Disclosure, Government, Adjustment, Conference, Wind, Climate change, Disagreement, Environmental Health (journal), Tax, Security (finance), Risk, Professional, Insurance, Depreciation

TEL AVIV, Israel, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Enlight Renewable Energy Ltd. (NASDAQ: ENLT, TASE: ENLT) today reported financial results for the fourth quarter and full year ended December 31, 2023. The Company’s earnings webcast will be held today at 8:00 AM ET. A link to this webcast can be found at the end of this earnings release.

Key Points: 
  • 4 The section titled “Non-IFRS Financial Measures” below contains a description of Adjusted EBITDA, a non-IFRS financial measure discussed in this press release.
  • A reconciliation between Adjusted EBITDA and Net Income, its most directly comparable IFRS financial measure, is contained in the tables below.
  • Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.
  • Enlight plans to hold its Fourth Quarter 2023 Conference Call and Webcast on Monday, February 26, 2024 at 8:00 a.m.

Evogene Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024
Shekel, Growth, Sale, Perception, Health, Webcast, Fruit, Herbicide, AG, Generator, CFIA, Marketing, Seed, Canadian Food Inspection Agency, CPB, Therapy, Production, ICL, Burn, Conference, Safety, Collaboration, Patent, CO2, Agreement, Insurance, Visceral pain, Agricultural science, Gene editing, EIC, Probiotic, Computational biology, Patient, Israeli new shekel, IBS, Pharmaceutical industry

REHOVOT, Israel, March 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product discovery and development utilizing cutting edge computational biology technologies, across multiple market segments, today announced its financial results for the fourth quarter and full-year period ending December 31, 2023.

Key Points: 
  • Collaboration with Colors Farm and Ben Gurion University: Evogene partnered to pioneer crustacean gene editing technology aimed at enhancing crustacean traits.
  • EU Grant for Ag-Seed Division: Evogene secured a €1.2 million EU grant to develop oil-seed crops with enhanced CO2 assimilation and drought tolerance.
  • In the fourth quarter of 2023, general and administrative expenses were approximately $1.2 million, down from about $1.7 million in the same period the previous year.
  • This increase in net loss during the fourth quarter of 2023 is primarily attributed to other income received in 2022, as mentioned above.

Actelis Networks Reports Third Quarter 2023

Retrieved on: 
Tuesday, November 14, 2023
Shekel, EBITDA, Research, Frontier Communications, Loss, Internet of things, Organization, Investment, Marketing, ASNS, EVP, Government, Federal, UL, IPO, Operating cost, Growth, FIPS, Certification, Computer, SW, Cryptocurrency, Mobile phone, Video game, Agriculture, Security (finance), Birth control, Telco, Navigation Acts, MDU

FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment Hybrid-Fiber networking solutions for wide area IoT applications, today reported financial results for the fiscal third quarter and nine months ended September 30, 2023.

Key Points: 
  • FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment Hybrid-Fiber networking solutions for wide area IoT applications, today reported financial results for the fiscal third quarter and nine months ended September 30, 2023.
  • Third Quarter and nine months of 2023 Financial Highlights:
    Revenues were $0.85 million for the third quarter of 2023 compared to $1.35 million in the year ago period, as significant new orders expected to close in the third quarter were delayed to the fourth quarter of the year.
  • Operating expenses for the third quarter 2023 were $2.35 million, flat compared to $2.35 million sequentially helped by cost reductions implemented during the second quarter of 2023, offset by investments in sales and marketing.
  • Operating expenses for the third quarter 2023 decreased to $2.35 million compared to $2.54 million in the year ago period, due to cost reductions implemented during the second quarter of 2023.

MarketVector Indexes Licenses the MCM-BlueStar® Israel Bonds Index to Defiance for the first-ever Israel Bond ETF (CHAI)

Retrieved on: 
Wednesday, December 13, 2023
Other Professional Services, Professional Services, Finance, Shekel, ETF, Corporation, ILS, NYSE, Government, Corporate bond, USD, CHAI, Partnership, Third government of Israel, United States dollar, Security (finance), Defiance, Index

MarketVector IndexesTM (“MarketVector”) announces the licensing of the MCM-BlueStar® Israel Bonds Index (MBILB) to Defiance ETFs .

Key Points: 
  • MarketVector IndexesTM (“MarketVector”) announces the licensing of the MCM-BlueStar® Israel Bonds Index (MBILB) to Defiance ETFs .
  • The firm today launched the Defiance Israel Bond ETF (NYSE Ticker: CHAI), a first-of-its-kind fund that invests in Israeli government and corporate bonds, offering diversified exposure to the Israeli fixed-income market.
  • The CHAI ETF will track the MCM-BlueStar® Israel Bonds Index.
  • “We are proud to partner with Defiance to support the launch of their innovative and pioneering Israel Bond ETF,” said Steven Schoenfeld, CEO of MarketVector.

VBI Vaccines Reports Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 14, 2023
Biotechnology, FDA, Other Health, Health, Pharmaceutical, Oncology, Research, Infectious Diseases, Science, COVID-19, Clinical Trials, Shekel, MLE, High-net-worth individual, Hepatitis B vaccine, GMT, HBsAg, Net, AASLD, Bank statement, Disease, GBM, Government, Administration, Patient, HBV, Research and development, Prison, Allergy, Fast track (FDA), Autoimmune disease, InSight, Liver, VBI, Messenger, Internationalized domain name, GAAP, Vaccine, Cancer, Partnership, R, Seroconversion, Growth, Infection, Israeli new shekel, Pharmaceutical industry, Video game, Rare-earth element, Cryptocurrency, Bank

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended September 30, 2023.

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended September 30, 2023.
  • Cost of Revenues: Cost of revenues was $2.5 million in the third quarter of 2023 as compared to $2.7 million in the third quarter of 2022.
  • Research and Development (R&D): R&D expenses for the third quarter of 2023 were $1.5 million as compared to $5.0 million for the third quarter of 2022.
  • Non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with, GAAP financial results.

MAGIC SOFTWARE ANNOUNCES SELECTED PRELIMINARY THIRD QUARTER 2023 FINANCIAL RESULTS

Retrieved on: 
Wednesday, November 8, 2023
Shekel, Hamas, Magic Software Enterprises, GAAP, NIS, Exercise, Judgement, Magic, Bank statement, TASE, Health Management Associates (Florida company), MGIC, Beauty salon, Video game, Bank

Or Yehuda, Israel, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (the “Company”), a global provider of IT consulting services and end-to-end integration and application development platforms solutions, today provided certain selected preliminary unaudited financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Company will announce results for the third quarter of 2023 on November 14, 2023
    Or Yehuda, Israel, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (the “Company”), a global provider of IT consulting services and end-to-end integration and application development platforms solutions, today provided certain selected preliminary unaudited financial results for the third quarter ended September 30, 2023.
  • Magic Software’s management will host a conference call on Tuesday, November 14, 2023, at 9:00 am Eastern Standard Time (16:00 Israel time) to review and discuss Magic Software’s third quarter 2023 results.
  • Magic Software believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Magic Software’s financial condition and results of operations.
  • Magic Software urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business.

Cronos Group Reports 2023 Third Quarter Results

Retrieved on: 
Wednesday, November 8, 2023
Shekel, Gems, Cannabis, Sale, Vii, Biomass, Flower, Fleming Companies, Inc, Tax, Pressure, Genetics, Grow Up, Wind, CBN, Research, GMO, CBG, Edible, Q3, Growth, Spinach, Marketing, Lord, Pharmacy, Capital expenditure, CBC, Depreciation, Cannabinol, Cannabinoid, Investment, THCV, Capital, Peace, Bookkeeping, Drug, Pharmaceutical industry, Security (finance), Cronos

Furthermore, the weakened Canadian dollar and New Israeli Shekel against the U.S. dollar during the period adversely impacted results.

Key Points: 
  • Furthermore, the weakened Canadian dollar and New Israeli Shekel against the U.S. dollar during the period adversely impacted results.
  • Cronos GrowCo reported to the Company preliminary unaudited net revenue to licensed producers, excluding sales to the Company, of approximately $6.2 million in the third quarter of 2023.
  • In addition to principal repayment, Cronos also received $1.2 million in interest payments from GrowCo, totaling approximately $2.3 million in cash payments to Cronos in Q3 2023.
  • ET to discuss 2023 Third Quarter business results.

Caesarstone Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 8, 2023
Architecture, Construction & Property, Other Manufacturing, Engineering, Other Construction & Property, Interior Design, Manufacturing, Residential Building & Real Estate, Shekel, Adjustment, United States dollar, Policy, Operating cost, CSTE, EBITDA, Absorption, Conference, Exercise, Rehabilitation, Crime, Webcast, Trade-weighted US dollar index, Terror, Caesarstone, Video game, Pharmaceutical industry, Bank

Caesarstone Ltd. (NASDAQ: CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its third quarter ended September 30, 2023.

Key Points: 
  • Caesarstone Ltd. (NASDAQ: CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its third quarter ended September 30, 2023.
  • Gross margin in the third quarter of 2023 was 19.1% compared to 23.0% in the prior year quarter.
  • Operating loss in the third quarter of 2023 was $2.0 million compared to operating income of $3.2 million in the prior year quarter.
  • Finance income in the third quarter of 2023 was $1.3 million compared to finance expenses of $4.3 million in the prior year quarter.